1. Home
  2. SNOA vs GLMD Comparison

SNOA vs GLMD Comparison

Compare SNOA & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$1.12

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Galmed Pharmaceuticals Ltd.

GLMD

Galmed Pharmaceuticals Ltd.

N/A

Current Price

$0.57

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNOA
GLMD
Founded
1999
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.0M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
SNOA
GLMD
Price
$1.12
$0.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
84.2K
305.4K
Earning Date
06-16-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
32.26
N/A
EPS
N/A
N/A
Revenue
$19,529,000.00
N/A
Revenue This Year
$23.00
N/A
Revenue Next Year
$24.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.68
N/A
52 Week Low
$0.85
$0.41
52 Week High
$6.92
$2.34

Technical Indicators

Market Signals
Indicator
SNOA
GLMD
Relative Strength Index (RSI) 40.90 44.46
Support Level $1.02 $0.53
Resistance Level $1.25 $0.69
Average True Range (ATR) 0.08 0.08
MACD 0.02 -0.00
Stochastic Oscillator 30.43 56.17

Price Performance

Historical Comparison
SNOA
GLMD

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Share on Social Networks: